Insights into Eph Receptor Tyrosine Kinase Activation from Crystal Structures of the EphA4 Ectodomain and Its Complex with Ephrin-A5
Overview
Authors
Affiliations
Eph receptor tyrosine kinases and their ephrin ligands mediate cell signaling during normal and oncogenic development. Eph signaling is initiated in a multistep process leading to the assembly of higher-order Eph/ephrin clusters that set off bidirectional signaling in interacting cells. Eph and ephrins are divided in two subclasses based on their abilities to bind and activate each other and on sequence conservation. EphA4 is an exception to the general rule because it can be activated by both A- and B-class ephrin ligands. Here we present high-resolution structures of the complete EphA4 ectodomain and its complexes with ephrin-A5. The structures reveal how ligand binding promotes conformational changes in the EphA4 ligand-binding domain allowing the formation of signaling clusters at the sites of cell-cell contact. In addition, the structural data, combined with structure-based mutagenesis, reveal a previously undescribed receptor-receptor interaction between the EphA4 ligand-binding and membrane-proximal fibronectin domains, which is functionally important for efficient receptor activation.
Constrained β-Hairpins Targeting the EphA4 Ligand Binding Domain.
Prentiss A, Baggio C, Pagett J, Kulinich A, Ethell I, Muzzarelli K J Med Chem. 2024; 67(24):22245-22253.
PMID: 39656022 PMC: 11684737. DOI: 10.1021/acs.jmedchem.4c02286.
Co-clustering of EphB6 and ephrinB1 in trans restrains cancer cell invasion.
Liang L, Geoghegan N, Mlodzianoski M, Leis A, Whitehead L, Surudoi M Commun Biol. 2024; 7(1):461.
PMID: 38627519 PMC: 11021433. DOI: 10.1038/s42003-024-06118-4.
Eph receptors and ephrins in cancer progression.
Pasquale E Nat Rev Cancer. 2023; 24(1):5-27.
PMID: 37996538 PMC: 11015936. DOI: 10.1038/s41568-023-00634-x.
Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly.
Shi X, Lingerak R, Herting C, Ge Y, Kim S, Toth P Science. 2023; 382(6674):1042-1050.
PMID: 37972196 PMC: 11114627. DOI: 10.1126/science.adg5314.
Ephrin-Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies.
Mekala S, Dugam P, Das A J Cell Commun Signal. 2023; 17(3):549-561.
PMID: 37103689 PMC: 10409970. DOI: 10.1007/s12079-023-00750-1.